Detailed product-level analysis for benchmarking and improving the performance of medical affairs teams in the EU5
Clinicians treating rheumatoid arthritis need the ongoing support of medical affairs teams to ensure complete knowledge of a product’s clinical value and use. The quality of a medical affairs team’s response and service is critical in supporting prescribing and treatment decisions, so how do front-line physicians rate the service they get and where do they see room for improvement?
This and other key questions are answered in this insightful July 2019 analysis of 12 leading rheumatoid arthritis brands. Based on the results of an in-depth survey of 150 EU5-based rheumatologists, Medical Affairs Reputations (EU5) Rheumatoid Arthritis identifies the drivers that build clinician satisfaction and brand loyalty.
Medical affairs teams from leading companies in rheumatoid arthritis assessed
Leading brands covered in this report
Answering important medical affairs performance questions
Exclusive to FirstView, Medical Affairs Reputations surveys reveal, at a brand level, physician satisfaction with the medical affairs services they receive and the key areas where teams can improve their performance
The experience of the physicians surveyed
This detailed analysis is based on a survey of 150 EU5 dermatologists and rheumatologists with a wealth of experience treating rheumatoid arthritis. On average they:
This report gives you...
Why FirstView has an edge in pharmaceutical market research
FirstView research draws on LiMA (Leaders in Medicine Atlas), the world's largest directory of 3.5 million vetted and verified physicians. This proprietary physician research platform uses advanced big data capture, processing and analytics powered by AI and machine learning to ensure the most robust samples are used for every FirstView survey.
Other RHEUMATOID ARTHRITIS reports available
Medical Affairs Reputations US: Rheumatoid Arthritis
Market Access Impact US: Rheumatoid Arthritis
Market Access Impact Europe: Rheumatoid Arthritis
NPS+ US: Rheumatoid Arthritis
NPS+ Europe: Rheumatoid Arthritis
To learn about our cost effective Rheumatoid Arthritis intelligence package of all reports, please contact us at info@fwreports.com
All Contents Copyright © 2021 Doctor's Guide Publishing Limited All Rights Reserved